Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyperAcute Melanoma Vaccine + PEG-Intron in Advanced Melanoma
NCT00746746Phase 2Unknown
- Sponsor
- Ochsner Clinic Foundation
- Start
- Jun 2008
- Primary completion
- Jun 2010
- Modality
- Cell Therapies, Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of dorgenmeltucel-L in melanoma, sponsored by Ochsner Clinic Foundation. Status: unknown.
02
Drugs
dorgenmeltucel-L
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00746746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746746.